enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Liraglutide - Wikipedia

   en.wikipedia.org/wiki/Liraglutide

   Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. [6] [7] It is a second-line therapy for diabetes following first-line therapy with metformin. [6] [8] Its effects on long-term health outcomes like heart disease and life expectancy are unclear.

3. Weight Loss Injections: What You Need to Know, From ... - AOL

   www.aol.com/weight-loss-injections-know-costs...

   Liraglutide Weight Loss Injections. Liraglutide is the active ingredient in Saxenda and Victoza. Like Ozempic and Wegovy, liraglutide is an injected GLP-1 receptor agonist that can suppress ...

4. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

   www.aol.com/diabetes-drugs-really-safe-reliable...

   Victoza is FDA-approved to treat type 2 diabetes but is also sometimes prescribed off-label for weight loss. Saxenda is FDA-approved for weight management in people with obesity. 3.

5. How to preserve muscle mass on weight-loss drugs like Wegovy

   www.aol.com/preserve-muscle-mass-weight-loss...

   Studies using MRI showed that liraglutide (Victoza), a GLP-1 agonist used for diabetes, and tirzepatide (Zepbound) led to muscle loss that was expected with the observed magnitude of weight loss ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   A 2010 phase 2 trial found cetilistat significantly reduced weight and was better tolerated than orlistat. [ 34 ] SGLT2 inhibitors cause the loss of 60–100 grams (2.1–3.5 oz) glucose in the urine each day and are associated with a modest, sustained weight loss of 1.5–2 kilograms (3.3–4.4 lb) in people with type 2 diabetes.

7. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

8. Victoza: Generic GLP-1 Drug Similar to Ozempic Now Available

   www.aol.com/lifestyle/victoza-generic-glp-1-drug...

   Glucagon-like peptide-1 receptor agonists (otherwise known as GLP-1s or GLP-1 RAs) are a class of incretin drugs that mimic the body’s natural hormones to help treat diabetes and obesity.

9. Metabolic acidosis - Wikipedia

   en.wikipedia.org/wiki/Metabolic_acidosis

   Metabolic acidosis is a serious electrolyte disorder characterized by an imbalance in the body's acid-base balance.Metabolic acidosis has three main root causes: increased acid production, loss of bicarbonate, and a reduced ability of the kidneys to excrete excess acids. [5]